APA (7th ed.) Citation

Regillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008). Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1. American journal of ophthalmology, 145(2), 239-248.e5. https://doi.org/10.1016/j.ajo.2007.10.004

Chicago Style (17th ed.) Citation

Regillo, Carl D., David M. Brown, Prema Abraham, Huibin Yue, Tsontcho Ianchulev, Susan Schneider, and Naveed Shams. "Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1." American Journal of Ophthalmology 145, no. 2 (2008): 239-248.e5. https://doi.org/10.1016/j.ajo.2007.10.004.

MLA (9th ed.) Citation

Regillo, Carl D., et al. "Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1." American Journal of Ophthalmology, vol. 145, no. 2, 2008, pp. 239-248.e5, https://doi.org/10.1016/j.ajo.2007.10.004.